- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04591093
Auditory Performances With Different Stimulation Depths in Cochlear Implanted Subjects Using a Fine Structure Strategy
Study of Musical Perception and Post-operative Auditory Performance as a Function of the Depth of Stimulation in Subjects Implanted With a MED-EL Cochlear Implant and Using a FineHearing Strategy Single-center Randomized Cross-over Study
Main objective:
Investigate on new cochlear implanted patients whether the FineHearing strategy of the MED-EL cochlear implant gives better results on musical perception if the depth of stimulation (stimulation or not of the apical areas) is greater.
Secondary objectives:
Evaluate the effect of stimulation depth on vocal audiometric results, results of differential frequency threshold test and on qualitative sound perception.
Study Overview
Status
Conditions
Detailed Description
Introduction:
Conventional stimulation strategies in cochlear implants (e.g. ACE, CIS) use the place of the electrode to code the frequency by sending low frequency information on the apical electrodes and high frequency information on the basal electrodes. The stimulation rate of the electrodes is constant.
The pitch is only partially transmitted by these conventional strategies which would explain the poor results of cochlear implants in the perception of music.
In the FineHearing strategy of the MED-EL implant, the rate of stimulation on the low-frequency electrodes is related to the frequency of the sound and makes it possible to code the frequency information temporally.
Rader & al. 2016 have studied the contribution of adding to the tonotopic coding of the frequency (classical strategy) a temporal coding of the information by varying the stimulation rate. The results obtained show that providing this frequency information by time coding makes it possible to obtain perceived pitch much closer to the expected pitch (of normal-hearing) and less variability, especially at low frequencies. With fixed stimulation rate (classical strategy) low frequencies are poorly coded, whereas with the variable stimulation rate they are better coded.
In addition, Landsberger et al. [2018] studied in six subjects with a MED-EL implant the perception of a temporal coding according to the position of the electrodes with a long insertion: middle or apical position. The results seem to show that the temporal coding of the frequency would be more reliable than the spatial coding (related to the position of the electrode) at the apex, and the reverse on the electrodes in the middle position.
Studies have shown that the FineHearing strategy can provide benefits over the classic HDCIS strategy in tasks involving the fundamental F0 such as speech recognition in noise (after a certain learning time) [Kleine Punte & al. 2014 ; Vermeire & al. 2010], the perception of music [Roy & al. 2015 ; Roy & al. 2016] or the perceived quality of pitch [Müller & al. 2012].
The results obtained seem to depend on the position of the electrode: a deep insertion to reach the apical zone of the cochlea would allow better coding of the information.
MED-EL's FineHearing coding strategy with stimulation of the apical areas of the cochlea (long insertion of electrodes) could therefore allow better transmission of musical pitch and in particular improve the subjective quality of music compared to the same stimulation strategy without reaching the apical areas (short insertion).
Objective of the study: The objective of the study is to evaluate if the FineHearing strategy of MED-EL with stimulation of the apical zones allows to better transmit musical pitch and in particular to improve the subjective quality of the music compared to the same stimulation strategy without apical stimulation.
Main objective:
Show that the FineHearing strategy of MED-EL with stimulation of the apical zones allows to obtain a better perceptual quality of music in newly implanted cochlear patients than the same strategy without apical stimulation.
Secondary objectives:
- Evaluate differential frequency thresholds and correlation with qualitative perceptions of music.
- Evaluate the effect of the stimulation of the apical zones on the results of speech audiometry with the FineHearing strategy.
- Evaluate the effect of the stimulation of the apical zones on the subjective quality of sounds by questionnaire with the FineHearing strategy.
Plan of study:
it is a Single-center, randomized, double-blind, cross-over study
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Vincent Péan, PhD
- Phone Number: (+33) 603592974
- Email: vincent.pean@medel.com
Study Locations
-
-
-
Paris, France, 75651 Paris Cedex 13
- Recruiting
- GH Pitié-Salpêtrière, APHP 6
-
Contact:
- Isabelle Mosnier, Dr
- Phone Number: (+33) 1 42 16 26 06
- Email: isabelle.mosnier@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patient (≥ 18 years old) speaking French
- Patient who fulfils the criteria for cochlear implantation
- Patient with a postoperative insertion angle of the apical electrode > 450°
- Patient with 12 active electrodes on the day of activation.
Exclusion Criteria:
- Retro-cochlear pathology: auditory neuropathy, vestibular schwannoma
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CI with FineHearing with 10 more apical electrodes activated then 10 more basal electrodes activated
Cochlear implant with FineHearing Strategy with 10 more apical electrodes activated first during 1 month then FineHearing Strategy with 10 more basal electrodes activated during 1 month
|
Cochlear implant with FineHearing Strategy with 10 more apical electrodes activated or with 10 more basal electrodes activated
|
Active Comparator: CI with FineHearing with 10 more basal electrodes activated then 10 more apical electrodes activated
Cochlear implant with FineHearing Strategy with 10 more basal electrodes activated first during 1 month then FineHearing Strategy with 10 more apical electrodes activated during 1 month
|
Cochlear implant with FineHearing Strategy with 10 more apical electrodes activated or with 10 more basal electrodes activated
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Qualitative measure of music with direct audio link
Time Frame: at 1 month post-activation
|
The Gabrielsson scale (1988) is used to evaluate perceived sound quality as a multidimensional phenomenon, that is composed of a number of separate perceptual dimensions. Eight perceptual dimensions are evaluated: clarity, fullness, brightness vs dullness, hardness/sharpness vs softness, spaciousness, nearness, extraneous sounds, loudness. Visual analog scales (VAS) are used for each dimension and the patient has to score the dimension on a 10 cm VAS (between 0 to 10). The test is performed with a direct audio link to the CI. |
at 1 month post-activation
|
Qualitative measure of music with direct audio link
Time Frame: at 2 months post-activation
|
The Gabrielsson scale (1988) is used to evaluate perceived sound quality as a multidimensional phenomenon, that is composed of a number of separate perceptual dimensions. Eight perceptual dimensions are evaluated: clarity, fullness, brightness vs dullness, hardness/sharpness vs softness, spaciousness, nearness, extraneous sounds, loudness. Visual analog scales (VAS) are used for each dimension and the patient has to score the dimension on a 10 cm VAS (between 0 to 10). The test is performed with a direct audio link to the CI. |
at 2 months post-activation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Qualitative measure of music
Time Frame: at 1 month post-activation
|
The Gabrielsson scale (1988) is used to evaluate perceived sound quality as a multidimensional phenomenon, that is composed of a number of separate perceptual dimensions. Eight perceptual dimensions are evaluated: clarity, fullness, brightness vs dullness, hardness/sharpness vs softness, spaciousness, nearness, extraneous sounds, loudness. Visual analog scales (VAS) are used for each dimension and the patient has to score the dimension on a 10 cm VAS (between 0 to 10). The test is performed in free field without any contralateral aid. |
at 1 month post-activation
|
Qualitative measure of music
Time Frame: at 2 months post-activation
|
The Gabrielsson scale (1988) is used to evaluate perceived sound quality as a multidimensional phenomenon, that is composed of a number of separate perceptual dimensions. Eight perceptual dimensions are evaluated: clarity, fullness, brightness vs dullness, hardness/sharpness vs softness, spaciousness, nearness, extraneous sounds, loudness. Visual analog scales (VAS) are used for each dimension and the patient has to score the dimension on a 10 cm VAS (between 0 to 10). The test is performed in free field without any contralateral aid. |
at 2 months post-activation
|
Speech recognition in quiet
Time Frame: at 1 month post-activation
|
The speech recognition in quiet is evaluated with 3 monosyllabic list of 17 words at 60 dB SPL.
The patient has to recognize 17 words and 51 phonemes.
The words and phonemes are scored: each good answer is scored 1 yielding a total between 0 and 1 for the words and the phonemes (or 0% and 100%).
|
at 1 month post-activation
|
Speech recognition in quiet
Time Frame: at 2 months post-activation
|
The speech recognition in quiet is evaluated with 3 monosyllabic list of 17 words at 60 dB SPL.
The patient has to recognize 17 words and 51 phonemes.
The words and phonemes are scored: each good answer is scored 1 yielding a total between 0 and 1 for the words and the phonemes (or 0% and 100%).
|
at 2 months post-activation
|
Differential frequency threshold
Time Frame: at 1 month post-activation
|
This test aimed to determine the smallest perceptible difference in F0 between two stimuli for various baseline values of F0.
An adaptive procedure is used.
|
at 1 month post-activation
|
Differential frequency threshold
Time Frame: at 2 months post-activation
|
This test aimed to determine the smallest perceptible difference in F0 between two stimuli for various baseline values of F0.
An adaptive procedure is used.
|
at 2 months post-activation
|
Sound quality
Time Frame: at 1 month post-activation
|
The HISQUI questionnaire will be used to evaluate the sound quality.
The HISQUI questionnaire (Hearing Implant Sound Quality Index) is a questionnaire on the perceptual quality of sounds given a score (maximum=203) for each patient which indicates how he/she perceives the sound quality with his/her hearing implant in the everyday life.
|
at 1 month post-activation
|
Sound quality
Time Frame: at 2 months post-activation
|
The HISQUI questionnaire will be used to evaluate the sound quality.
The HISQUI questionnaire (Hearing Implant Sound Quality Index) is a questionnaire on the perceptual quality of sounds given a score (maximum=203) for each patient which indicates how he/she perceives the sound quality with his/her hearing implant in the everyday life.
|
at 2 months post-activation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Isabelle Mosnier, Dr, Service ORL, UF Implants auditifs et explorations fonctionnelles GH Pitié-Salpêtrière, APHP 6 Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MED-EL_FS_stimdepth_frenchstud
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensorineural Hearing Loss, Bilateral
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
MED-EL Elektromedizinische Geräte GesmbHRecruitingSensorineural Hearing Loss, Bilateral | Bilateral Hearing LossFrance
-
MED-EL Elektromedizinische Geräte GesmbHCompletedSensorineural Hearing Loss, BilateralFrance
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
MED-EL Elektromedizinische Geräte GesmbHRecruitingSensorineural Hearing Loss, BilateralFrance
-
CochlearEVAMEDCompletedSensorineural Hearing Loss, BilateralFrance
-
MED-EL Elektromedizinische Geräte GesmbHWithdrawnSensorineural Hearing Loss, BilateralFrance
-
CochlearTerminatedSensorineural Hearing Loss, BilateralUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedHearing Impairment | Sensorineural Hearing Loss, BilateralUnited States
Clinical Trials on FineHearing Strategy with 10 more apical electrodes or with 10 more basal electrodes activated
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico